Free Trial

MBX Biosciences (MBX) Competitors

$14.33 +0.18 (+1.27%)
As of 08/22/2025

MBX vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

MBX Biosciences vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and MBX Biosciences (NASDAQ:MBX) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
MBX Biosciences N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled MBX Biosciences'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
MBX Biosciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
MBX BiosciencesN/AN/AN/A-$4.54-3.16

Summary

180 Life Sciences and MBX Biosciences tied by winning 0 of the 0 factors compared between the two stocks.

Get MBX Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

MetricMBX BiosciencesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$481.40M$833.52M$2.58B$9.76B
Dividend YieldN/A4.84%2.54%4.06%
P/E Ratio-3.161.1822.0426.05
Price / SalesN/A152.90274.2388.42
Price / CashN/A19.5624.1559.36
Price / BookN/A6.6431.916.60
Net IncomeN/A-$4.94M$31.01M$265.65M
7 Day PerformanceN/A1.85%1.08%2.00%
1 Month PerformanceN/A3.06%1.16%0.46%
1 Year PerformanceN/A12.25%28.72%18.88%

MBX Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
MBX Biosciences
N/A$14.33
+1.3%
N/AN/A$481.40MN/A-3.16N/AAnalyst Upgrade
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.22
+10.1%
N/A+2,400.6%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.46
+2.4%
N/AN/A$0.00$110.87K0.0040Gap Up
ALVOW
Alvotech
N/A$1.18
+4.3%
N/A-60.6%$0.00$560.10M0.004News Coverage
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/A-37.3%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-0.1%
N/AN/A$0.00$39.19M0.0070Gap Up
BTMDW
biote
N/A$0.01
-10.6%
N/A-95.5%$0.00$199.07M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.02
+18.4%
N/A-94.8%$0.00N/A0.008Gap Up

Related Companies and Tools


This page (NASDAQ:MBX) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners